New Key Statistics Module, Z-Score and F-Score
OTCPK:RLFTY Key Ratios
| Market Cap $ M | 88.09 |
| Enterprise Value $ M | 78.47 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 14.88 |
| Price/Book | 1.60 |
| Price/Sales | 9.14 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -4.17 |
| Beneish M-Score | -1.79 |
| 10-y EBITDA Growth Rate % | -9.00 |
| 5-y EBITDA Growth Rate % | -131.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.30 |
| EV-to-EBITDA | -1.39 |
| PEG | -- |
| Shares Outstanding M | 12.54 |
| Net Margin (%) | -538.23 |
| Operating Margin % | -142.86 |
| Pre-tax Margin (%) | -599.92 |
| Quick Ratio | 3.01 |
| Current Ratio | 3.09 |
| ROA % (ttm) | -50.80 |
| ROE % (ttm) | -70.82 |
| ROIC % (ttm) | -14.50 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.66 |
RLFTY Number of Guru Trades
RLFTY Volume of Guru Trades
Gurus Latest Trades with OTCPK:RLFTY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RLFTY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Relief Therapeutics Holding SA Insider Transactions
No Available Data
News about OTCPK:RLFTY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers